A Phase 2 Study to Assess the Safety, Tolerability, Exploratory Efficacy, and Pharmacokinetics of Orally Administered JBPOS0101 for Refractory Infantile Spasms Patients

Administered By

Awarded By

Contributors

Start/End

  • March 26, 2020 - December 31, 2021